| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | NEUTRAL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.58▼ | 7.56▲ | 7.53▲ | 7.63▼ | 7.28▲ |
| MA10 | 7.58▼ | 7.51▲ | 7.54▲ | 7.57▼ | 7.18▲ |
| MA20 | 7.58▲ | 7.54▲ | 7.57▲ | 7.29▲ | 7.60▼ |
| MA50 | 7.51▲ | 7.61▼ | 7.69▼ | 7.15▲ | 8.26▼ |
| MA100 | 7.51▲ | 7.69▼ | 7.39▲ | 7.64▼ | 7.43▲ |
| MA200 | 7.56▲ | 7.36▲ | 7.22▲ | 8.28▼ | 8.65▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | 0.018▲ | 0.001▲ | 0.043▲ | 0.025▲ |
| RSI | 55.545▲ | 52.708▲ | 49.223▼ | 57.178▲ | 47.053▼ |
| STOCH | 40.909 | 77.024 | 50.435 | 56.253 | 61.585 |
| WILL %R | -63.636 | -39.130 | -39.130 | -40.956 | -32.181 |
| CCI | 16.573 | 97.596 | 13.001 | 28.179 | 61.762 |
|
Friday, December 12, 2025 06:24 AM
BioCryst secures FDA approval for Orladeyo oral pellets, expanding preventive HAE therapy to children ages 2 to under 12.
|
|
Wednesday, October 29, 2025 05:00 PM
Fintel reports that on November 5, 2025, Citizens maintained coverage of BioCryst Pharmaceuticals (NasdaqGS:BCRX) with a Market Outperform recommendation. As of October 30, 2025, the average one-year ...
|
|
Wednesday, October 29, 2025 05:00 PM
As of October 30, 2025, the average one-year price target for BioCryst Pharmaceuticals is $21.51/share. The forecasts range from a low of $11.11 to a high of $31.50. The average price target ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/12/25 | 7.82 | 7.82 | 7.23 | 7.57 | 5,223,129 |
| 11/12/25 | 7.68 | 7.77 | 7.54 | 7.58 | 2,657,266 |
| 10/12/25 | 7.62 | 7.69 | 7.5101 | 7.66 | 2,734,990 |
| 09/12/25 | 7.70 | 7.85 | 7.63 | 7.64 | 3,220,568 |
| 08/12/25 | 7.71 | 7.9797 | 7.66 | 7.70 | 3,817,340 |
| 05/12/25 | 7.835 | 7.93 | 7.45 | 7.59 | 3,199,536 |
| 04/12/25 | 7.85 | 8.17 | 7.79 | 7.83 | 6,724,910 |
| 03/12/25 | 7.11 | 7.88 | 7.11 | 7.85 | 7,604,083 |
| 02/12/25 | 7.17 | 7.30 | 7.115 | 7.16 | 3,570,663 |
| 01/12/25 | 7.08 | 7.195 | 7.015 | 7.13 | 3,200,298 |
|
|
||||
|
|
||||
|
|